The Beauty Health Company ($SKIN) Investor Settlement

The parties have reached an agreement to settle the case, but the terms are still being finalized. You can submit your application now, and it will be processed once claims filing opens.

C.D. California

Court

2:23-cv-09733

Case number

05/10/2022

Class period Start

11/13/2023

Class period End

The Beauty Health Company has reached a tentative settlement to resolve investor claims that it misled the market about defects in its Syndeo devices, the resulting treatment interruptions, and the financial impact those problems had on the business.

Outline:

In March 2022, BeautyHealth launched Syndeo as the next generation of its HydraFacial system. Investors say the device had widespread design and performance problems from the start, causing clogs, low flow, screen failures, and repeated treatment interruptions. On November 13, 2023 it revealed a broader remediation plan, major charges, and more executive turnover. $SKIN fell 64.36% on November 14, 2023, and the case has now moved to a tentative settlement.

Timeline:
March 7, 2022: BeautyHealth announced the U.S. launch of Syndeo, its new digitally connected HydraFacial delivery system.
May 10, 2022: BeautyHealth reported first-quarter 2022 results and called the launch of Syndeo highly successful.
June 19, 2022: At the Jefferies Consumer Conference, BeautyHealth described Syndeo’s launch as flawless.
August 9, 2022: BeautyHealth reported second-quarter 2022 results and called the Syndeo rollout a tremendous success.
August 9, 2023: BeautyHealth disclosed lower gross margins tied in part to Syndeo-related issues, reduced margin guidance, and announced the departure of CFO Liyuan Woo.
November 13, 2023: BeautyHealth reported disappointing third-quarter 2023 results, lowered guidance, announced a major Syndeo remediation plan, and said CEO Andrew Stanleick would leave the company.
November 14, 2023: $SKIN fell 64.36%, erasing about $331.82 million in market value.
Background:

BeautyHealth sells HydraFacial systems and the consumables used with them. In March 2022, the company launched Syndeo as a major new connected device that was supposed to improve the provider and consumer experience.

Investors say BeautyHealth rushed Syndeo to market as consumable sales weakened and designed the system to work with the company’s own higher-margin consumables. But according to the case, the device launched with serious issues, including screen glitches, clogging, low flow, faulty parts, and other problems that interrupted treatments and frustrated customers.

The dispute also centers on what management knew. Investors say complaints surfaced almost immediately and that executives were kept informed through internal meetings, customer reports, and quality reviews, yet the company kept describing the launch as highly successful and customer feedback as strong.

As problems continued, BeautyHealth allegedly replaced defective machines with other machines that still had similar issues, while trying different fixes that did not fully solve the problem. Investors say this cycle hurt the company’s brand, strained customer relationships, and created mounting costs.

The market learned more in 2023. In August, BeautyHealth disclosed margin pressure and leadership changes, and in November it revealed that fixing or replacing thousands of Syndeo systems would require major charges and inventory write-downs. After those disclosures, $SKIN plunged, and the matter has now moved to a tentative settlement.

What Can Investors Expect Now?

The Beauty Health Company has reached a tentative settlement to resolve investor claims that it misled the market about defects in its Syndeo devices, the resulting treatment interruptions, and the financial impact those problems had on the business.

If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section.

Case Type

US Securities Class Action

Case Status

Tentative Settlement

Alleged Offence

Mismanagement,

Misleading Statements,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Filing date

11/16/2023

Lead Plaintiff Deadline

01/15/2024

Plaintiffs

Abduladhim A. Alghazwi

Attorneys

Robbins Geller Rudman & Dowd LLP

Defendants

Andrew Stanleick, Liyuan Woo, Michael Monahan

Judge

Maria A Audero

Trades matching type

FIFO

Frequently Asked Questions

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.